Fabiana Alexandrino

Fabiana Alexandrino

Auto-generated profile, based on publicly available information

Fabiana Alexandrino

Instituto de Biologia Molecular do Paraná, Brasil

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2010 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
KNKarin de A.B. Nivoloni
Karin de A.B. Nivoloni
SSSueli M. da Silva-Costa
Sueli M. da Silva-Costa
MPMariza C.A. Pomílio
Mariza C.A. Pomílio
TPTânia Pereira
Tânia Pereira
KLKaren de C. Lopes
Karen de C. Lopes
ESEdi L. Sartorato
Edi L. Sartorato

1 April 2005 in Revista Brasileira de Otorrinolaringologia
Verified
Journal Article
Open access
PDF file
VPVANIA BELINTANI PIATTO
VANIA BELINTANI PIATTO
ENEllen C.T. Nascimento
Ellen C.T. Nascimento
FAFabiana Alexandrino
Fabiana Alexandrino
COCamila A. Oliveira
Camila A. Oliveira
ALAna Cláudia P. Lopes
Ana Cláudia P. Lopes
JMJosé Victor Maniglia
José Victor Maniglia
Aproximadamente 1/1000 recém-nascidos apresentam deficiência auditiva congênita, sendo 60% dessas de etiologia genética. Na maioria dos casos, a deficiência auditiva é uma doença multifatorial causada por ambos os fatores, genéticos e ambientais. A genética molecular da deficiência auditiva tem apresentado grandes avanços na última década, pois os genes responsáveis pela deficiência auditiva hereditária vêm sendo progressivamente mapeados e clonados. Esta revisão enfatiza a deficiência auditiva não-sindrômica, uma vez que, os genes envolvidos nesse tipo de deficiência foram identificados recentemente.

1 September 2021 in Brazilian Journal of Biology
Verified
Journal Article
Open access
PDF file
FAF. Alexandrino
F. Alexandrino
JMJ. S. Malgarin
J. S. Malgarin
MKM. A. Krieger
M. A. Krieger
LML. G. Morello
L. G. Morello
Bacterial contamination of blood components remains a major challenge in transfusion medicine, particularly, platelet concentrates (PCs) due to the storage conditions that support bacterial proliferation. In this study, we develop a rapid, sensitive and specific real-time PCR protocol for bacterial screening of PCs. An internally controlled real-time PCR-based method was optimized and validated with our proprietary 16S Universal PCR Master Mix (IBMP/Fiocruz), which targets a conserved region of the bacterial 16S rRNA gene. Nonspecific background DNA was completely eliminated by treating the PCR Master Mix with ethidium monoazide (EMA). A lower limit of detection was observed for 10 genome equivalents with an observed Ct value of 34±1.07 in calibration curve generated with 10-fold serial dilutions of E. coli DNA. The turnaround time for processing, including microbial DNA purification, was approximately 4 hours. The developed method showed a high sensitivity with no non-specific amplification and a lower time-to-detection than traditional microbiological methods, demonstrating it to be an efficient means of screening pre-transfusion PCs.